New Israeli vaccine being tested in Hungary
Israel is developing a new vaccine, and Hungary is the first European country to join the program and test the new Israeli vaccine.
The development of the new vaccine and the test phase
Israel has been developing its own COVID-19 vaccine. Research and development have been going on for a year and a half, says egészségkalauz.hu. Phase 2b / 3 of the Israeli vaccine called BriLife is currently being tested. Hungary is the first in Europe to test the vaccine.
The developers of Israel’s own vaccine are the pharmaceutical company NRx in collaboration with the Israel Institute for Biological Research (IIBR).
How the vaccine works
The vesicular stomatitis virus (VSV), which is a virus that infects animals such as cattle, horses and pigs, serves as the cure. This virus is genetically modified so that SARS-CoV-2 coronavirus spike proteins can grow on its surface, explains atv.hu. The genetically modified vesicular stomatitis virus (rVSV) is then administered to the human body in a living form. The virus, although not a coronavirus, contains spikes on its surface due to genetic engineering modifications.